Medlab reformulates cannabinoid pain drug into synthetic as it progresses to phase III – BioWorld

9 October 2021 Editor Leave a comment

PERTH, Australia – After meeting with the FDA, Medlab Clinical Ltd. is reformulating its cannabinoid pain product into a synthetic formulation because the …

Dagga Magazine

Medlab reformulates cannabinoid pain drug into synthetic as it progresses to phase III – BioWorld

Leave a Reply Cancel reply

Latest South African Dagga Culture, Activism, Alternative News & Trends – AmaDaggafarian